Level Biotechnology Inc.
3118
Rank in Stocks
#24880
Level Biotechnology Inc., founded in 1989 and based in New Taipei City, Taiwan,... Level Biotechnology Inc., founded in 1989 and based in New Taipei City, Taiwan, operates in the commercialization and distribution of scientific products and services. The company supplies specialized reagents and consumables for cell culture, immunology, and molecular biology, alongside advanced biomedical instrumentation, throughout Taiwan. Beyond product distribution, Level Biotechnology offers a comprehensive suite of research and testing services. These include expert assessments in mammalian and genetic toxicology, pharmacological studies, biocompatibility testing, and the production of model animals. The firm's preclinical research capabilities serve a diverse range of clients in the biotechnology, pharmaceutical, medical device, animal health, and agrichemical industries.
Share Price
$0.92063065
Last synced: 2026-11-10
Market Cap
$29.88M
Change (1 day)
-0.33%
Change (1 year)
-15.58%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Level Biotechnology Inc. (3118)
Category
Healthcare
Operating Margin for Level Biotechnology Inc. (3118)
Operating Margin as of November 2026 TTM: 12.04%
According to Level Biotechnology Inc.'s latest financial reports, its current operating margin (TTM) is 12.04%. At the end of 2025 the company had an operating margin of 11.34%.
Operating Margin history for Level Biotechnology Inc. from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 12.04% | 6.17% |
| 2025 | 11.34% | 10.20% |
| 2024 | 10.29% | 0.59% |
| 2023 | 10.23% | -6.49% |
| 2022 | 10.94% | -6.17% |
| 2021 | 11.66% | 18.50% |
| 2020 | 9.84% | 11.44% |
| 2019 | 8.83% | 12.92% |
| 2018 | 7.82% | -44.10% |
| 2017 | 13.99% | -3.58% |
| 2016 | 14.51% | -11.74% |
| 2015 | 16.44% | -1.14% |
| 2014 | 16.63% | 17.69% |
| 2013 | 14.13% | 13.95% |
| 2012 | 12.40% | -13.65% |
| 2011 | 14.36% | -1.10% |
| 2010 | 14.52% | 35.32% |
| 2009 | 10.73% | -25.23% |
| 2008 | 14.35% | 18.60% |
| 2007 | 12.10% | -14.61% |
| 2006 | 14.17% | 53.19% |
| 2005 | 9.25% | 38.89% |
| 2004 | 6.66% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -96.79% |
US
|
|
| -149.01% | -112.38% |
US
|
|
| 25.57% | -97.88% |
AU
|
|
| 31.23% | -97.41% |
BE
|
|
| 29.35% | -97.56% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Level Biotechnology Inc.'s operating margin
What is Level Biotechnology Inc.'s operating margin?
Level Biotechnology Inc.'s operating margin is 12.04%, as of Nov 2026.
What was Level Biotechnology Inc.'s operating margin in 2025?
In 2025, Level Biotechnology Inc.'s operating margin was 11.34%, compared with 10.29% in 2024.
How has Level Biotechnology Inc.'s operating margin changed since 2020?
From 2020 to 2025, Level Biotechnology Inc.'s operating margin was highest in 2021 (11.66%) and lowest in 2020 (9.84%).
How does Level Biotechnology Inc.'s operating margin compare with similar companies?
Level Biotechnology Inc.'s operating margin (12.04%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.